273 related articles for article (PubMed ID: 19720914)
1. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.
Jones HA; Antonini N; Hart AA; Peterse JL; Horiot JC; Collin F; Poortmans PM; Oei SB; Collette L; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Schinagl DA; Wárlám-Rodenhuis CC; Bartelink H
J Clin Oncol; 2009 Oct; 27(30):4939-47. PubMed ID: 19720914
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.
Vrieling C; van Werkhoven E; Maingon P; Poortmans P; Weltens C; Fourquet A; Schinagl D; Oei B; Rodenhuis CC; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan DA; Dubois JB; Remouchamps V; Mirimanoff RO; Hart G; Collette S; Collette L; Bartelink H;
JAMA Oncol; 2017 Jan; 3(1):42-48. PubMed ID: 27607734
[TBL] [Abstract][Full Text] [Related]
3. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
4. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
[TBL] [Abstract][Full Text] [Related]
5. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?
Vrieling C; Collette L; Fourquet A; Hoogenraad WJ; Horiot JC; Jager JJ; Bing Oei S; Peterse HL; Pierart M; Poortmans PM; Struikmans H; Van den Bogaert W; Bartelink H;
Eur J Cancer; 2003 May; 39(7):932-44. PubMed ID: 12706362
[TBL] [Abstract][Full Text] [Related]
6. The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation.
Ono Y; Yoshimura M; Hirata K; Yamauchi C; Toi M; Suzuki E; Takada M; Hiraoka M; Mizowaki T
Radiat Oncol; 2019 Jul; 14(1):121. PubMed ID: 31291997
[TBL] [Abstract][Full Text] [Related]
7. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
8. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M
Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G
Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.
Kestin LL; Goldstein NS; Lacerna MD; Balasubramaniam M; Martinez AA; Rebner M; Pettinga J; Frazier RC; Vicini FA
Cancer; 2000 Feb; 88(3):596-607. PubMed ID: 10649253
[TBL] [Abstract][Full Text] [Related]
11. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
12. Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients.
Cambra MJ; Moreno F; Sanz X; Anglada L; Mollà M; Reyes V; Arenas M; Pedro A; Ballester R; García V; Casals J; Cusidó M; Jimenez C; Escribà JM; Macià M; Solé JM; Arcusa A; Seguí MA; Gonzalez S; Farrús B; Biete A
Clin Transl Oncol; 2020 May; 22(5):670-680. PubMed ID: 31264148
[TBL] [Abstract][Full Text] [Related]
13. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Coles CE; Griffin CL; Kirby AM; Titley J; Agrawal RK; Alhasso A; Bhattacharya IS; Brunt AM; Ciurlionis L; Chan C; Donovan EM; Emson MA; Harnett AN; Haviland JS; Hopwood P; Jefford ML; Kaggwa R; Sawyer EJ; Syndikus I; Tsang YM; Wheatley DA; Wilcox M; Yarnold JR; Bliss JM;
Lancet; 2017 Sep; 390(10099):1048-1060. PubMed ID: 28779963
[TBL] [Abstract][Full Text] [Related]
14. Conservation therapy in T1-T2 breast cancer: past, current issues, and future challenges and opportunities.
Perez CA
Cancer J; 2003; 9(6):442-53. PubMed ID: 14740972
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Krause M; Stenbygaard L; Mjaaland I; Schreiber A; Kasti UM; Overgaard J;
J Clin Oncol; 2020 Nov; 38(31):3615-3625. PubMed ID: 32910709
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy.
Vicini FA; Lacerna MD; Goldstein NS; Horwitz EM; Dmuchowski CF; White JR; Gustafson GS; Ingold JA; Martinez AA
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):627-35. PubMed ID: 9336142
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
18. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed.
Wazer DE; Schmidt-Ullrich RK; Ruthazer R; Schmid CH; Graham R; Safaii H; Rothschild J; McGrath J; Erban JK
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):851-8. PubMed ID: 9531370
[TBL] [Abstract][Full Text] [Related]
19. Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results.
Pierce LJ; Griffith KA; Hayman JA; Douglas KR; Lichter AS
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1317-27. PubMed ID: 15817333
[TBL] [Abstract][Full Text] [Related]
20. Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation.
Wazer DE; Jabro G; Ruthazer R; Schmid C; Safaii H; Schmidt-Ullrich RK
Radiat Oncol Investig; 1999; 7(2):111-7. PubMed ID: 10333252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
